2025 saw a bidding war between Pfizer and Novo Nordisk for Metsera and its portfolio of obesity agents, which was ultimately won by Pfizer for up to $10 billion
The proportion of patients achieving at least a 4.3-point increase from baseline in physical function, semaglutide versus placebo, was reported for STEP 1 (OR = 2.11 [95% CI, 1.53 to 2.91]), STEP 2 (OR = 1.72 [95% CI, 1.16 to 2.55]), STEP 3 (OR = 1.40 [95% CI, 0.80 to 2.44]), and STEP 4 (OR = 2.72 [95% CI, 1.18 to 6.29]) (Table 28)
The total number of hairs decreased by 24.1%, the number of vellus hairs decreased by 24.4%, and the numbers of terminal hair decreased by 30.0%
I covered the nootropic case and the delivery routes that avoid the smoke here
Beyond Weight: The Integrative Perspective At Refine by Tulsi, we approach perimenopause through the lens of longevity medicine
The results are gradual over a number of weeks as your body clears the broken down fatty tissues